Open AccessTHE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES
Author(s) -
Jeffrey S. Heier,
Rishi P. Singh,
Charles C. Wykoff,
Karl G. Csaky,
Timothy Y. Y. Lai,
Anat Loewenstein,
Patricio G. Schlottmann,
Liliana P Paris,
Peter D. Westenskow,
Carlos Quezada Ruiz
Publication year - 2021
Publication title -
retina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.24
H-Index - 120
eISSN - 1539-2864
pISSN - 0275-004X
DOI - 10.1097/iae.0000000000003003
Subject(s) - medicine , angiopoietin , clinical trial , vascular endothelial growth factor , retinal , bioinformatics , scope (computer science) , ophthalmology , intensive care medicine , pathology , cancer research , biology , vegf receptors , computer science , programming language
To provide a concise overview for ophthalmologists and practicing retina specialists of available clinical evidence of manipulating the angiopoietin/tyrosine kinase with immunoglobulin-like and endothelial growth factor-like domains (Tie) pathway and its potential as a therapeutic target in retinal vascular diseases.